{
  "pmcid": "11882278",
  "sha256": "14a6141ecdeda7fdf92b8f3d0fbae5a79141baa39153a050ebd5c51dcfa029a6",
  "timestamp_utc": "2025-11-09T15:25:17.123074+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 14.72225628930818,
    "reading_ease": 24.910931603773605,
    "word_count": 318
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "INSPIRE 2.0 was a randomized, controlled, parallel, multicenter study"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "randomized, controlled, parallel, multicenter study"
      },
      "Participants": {
        "score": 2,
        "evidence": "Patients with AIS grade A, thoracic (T2-T12), nonpenetrating SCI requiring spine surgery ≤7 days postinjury"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomized (1:1, computer-generated allocation) to undergo NSS implantation or spine surgery alone (control group)"
      },
      "Objective": {
        "score": 1,
        "evidence": "we evaluated whether NSS implantation demonstrates probable benefit for safety and neurological recovery in patients with thoracic complete SCI vs standard-of-care spine surgery"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "proportion of patients with improvement of ≥1 AIS grade at 6 months postsurgery (primary endpoint)"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "randomized (1:1, computer-generated allocation)"
      },
      "Blinding": {
        "score": 2,
        "evidence": "Patients and follow-up International Standards for Neurological Classification of SCI assessors were blinded"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Target enrollment was reached (N = 20) with 10 patients randomized and analyzed in each group"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "10 patients randomized and analyzed in each group"
      },
      "Result_Outcome": {
        "score": 1,
        "evidence": "At 6 months postsurgery, an improvement in the AIS grade was reported in 2 NSS patients (20%; both to AIS C) and 3 control group patients (30%; to AIS B [n = 2] or AIS C [n = 1])"
      },
      "Harms": {
        "score": 1,
        "evidence": "No serious or unanticipated adverse device effects were reported"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "ClinicalTrials.gov , NCT03762655"
      },
      "Funding": {
        "score": 1,
        "evidence": "funded by InVivo Therapeutics Corporation"
      }
    },
    "total_score": 19,
    "max_score": 25
  }
}